Leave Your Message
Explore our core product line engineered for oxygen concentration, gas drying, and medical-grade purification.
Molecular sieve materials — primarily zeolite-based crystalline aluminosilicates — are the cornerstone of modern medical oxygen generation technology. These highly porous materials possess precisely controlled pore sizes that selectively adsorb nitrogen, moisture, carbon dioxide, and other impurities from ambient air, yielding a concentrated oxygen stream of 90–96% purity suitable for clinical and industrial medical applications.
The most widely used type for oxygen generation is the Lithium-exchanged X-type (LiX) zeolite, also known as Li-LSX (Low Silica X). Its exceptional nitrogen adsorption capacity and selectivity over oxygen make it the material of choice for Pressure Swing Adsorption (PSA) and Vacuum Pressure Swing Adsorption (VPSA) oxygen concentrators — the two dominant technologies in medical oxygen supply today.
Key Principle: Molecular sieves for oxygen generation exploit the difference in polarizability between nitrogen (N₂) and oxygen (O₂). Nitrogen molecules are preferentially adsorbed onto the zeolite framework under pressure; when pressure is released, the sieve regenerates — enabling continuous, high-purity oxygen output with no consumable costs beyond electricity.
The global market for molecular sieve materials used in medical oxygen generation has expanded dramatically over the past decade. Driven by aging populations, increasing prevalence of respiratory diseases such as COPD and COVID-19, and the rapid expansion of healthcare infrastructure in emerging economies, demand for on-site PSA oxygen systems has surged across hospitals, clinics, and mobile medical units worldwide.
According to industry analysis, the global PSA oxygen generator market was valued at over USD 1.2 billion in 2023 and is projected to grow at a CAGR of approximately 7–9% through 2030. China, India, Southeast Asia, Africa, and Latin America are the fastest-growing markets, where centralized liquid oxygen supply chains are often impractical or cost-prohibitive.
Major molecular sieve producers — including companies in China, the United States, and Europe — are scaling up production capacity to meet this demand. Chinese manufacturers, in particular, have emerged as globally competitive suppliers of LiX and NaX zeolites, offering high-quality materials at competitive prices and with the production scale required for large hospital projects and government health infrastructure programs.
Next-generation LiX zeolites with optimized lithium exchange ratios (>95%) are achieving nitrogen working capacities 15–20% higher than standard grades, enabling smaller, lighter PSA units — critical for portable and home-use oxygen concentrators.
Advanced binder formulations and crystal engineering are extending the operational lifespan of molecular sieve beds to 10+ years under continuous PSA cycling, reducing maintenance downtime and total cost of ownership for hospital oxygen plants.
Regulatory trends in the EU, US (FDA), and China (NMPA) are driving stricter quality standards for molecular sieves used in medical devices. Manufacturers are investing in ISO 13485-aligned production and comprehensive trace-element testing.
VPSA technology, which uses molecular sieves optimized for sub-atmospheric desorption, is gaining ground in large hospital and industrial medical oxygen plants, cutting energy consumption by up to 30% compared to conventional PSA designs.
The home healthcare oxygen concentrator market is booming. Molecular sieve pellets and powder are being engineered in finer particle sizes and higher-density packing configurations to fit compact 5–10 LPM home devices used by COPD and post-COVID patients.
International health organizations (WHO, UNICEF) are actively promoting on-site PSA oxygen generation for hospitals in low-income countries, creating large-scale procurement demand for reliable, cost-effective molecular sieve materials.
Molecular sieve materials for medical oxygen generation serve a wide and growing spectrum of critical use cases.
Large hospitals operate PSA oxygen plants with twin-tower molecular sieve beds producing 10–500 Nm³/h of medical-grade oxygen. LiX zeolite with high nitrogen selectivity ensures consistent ≥93% O₂ purity as required by pharmacopoeial standards (BP, USP, EP). Molecular sieve longevity directly impacts hospital operational costs.
Military field hospitals, disaster relief operations, and mobile ICUs rely on portable PSA oxygen generators using compact molecular sieve columns. Rugged, vibration-resistant sieve pellets with high crush strength are essential to maintain performance under harsh transport and deployment conditions.
Home oxygen therapy devices for COPD, sleep apnea, and post-surgical recovery use miniaturized PSA columns filled with LiX or NaX molecular sieves. The global HOC market exceeded USD 2.5 billion in 2023 and is the fastest-growing segment driving demand for high-performance sieve materials in small-batch, precision formats.
HBOT chambers require ultra-high-purity oxygen (≥99%). Molecular sieves serve as the primary separation and pre-purification stage before final polishing, ensuring patient safety and therapeutic efficacy in wound healing, neurological rehabilitation, and sports medicine applications.
Bioreactors, fermenters, and sterile manufacturing environments require precise oxygen enrichment. Molecular sieve-based PSA systems provide on-demand, contaminant-free oxygen supply, eliminating the logistics and safety risks of cylinder storage in GMP-regulated pharmaceutical facilities.
In Sub-Saharan Africa, South Asia, and rural Southeast Asia, WHO-supported PSA oxygen projects are replacing unreliable cylinder supply chains. Molecular sieve quality and durability are paramount — systems must operate reliably for 5–10 years with minimal technical support, making material selection a life-critical decision.
In PSA oxygen generation, the molecular sieve is not merely a component — it IS the system. Every performance metric of the oxygen generator, from purity and flow rate to energy consumption and service life, is directly determined by the quality of the molecular sieve material. Key quality parameters include:
Shanghai Joozhou has been at the forefront of molecular sieve innovation for over two decades. Our deep technical expertise in zeolite synthesis, activation, and application engineering positions us as the preferred supplier for medical oxygen generation system manufacturers worldwide. We understand that in medical applications, there is zero tolerance for inconsistency — and our manufacturing processes, quality systems, and supply chain reliability reflect that commitment.
From initial R&D collaboration to full-scale production supply, we work alongside our customers at every stage to optimize molecular sieve performance for their specific PSA system design, operating conditions, and regulatory requirements. Our products are trusted by leading oxygen concentrator manufacturers and hospital infrastructure projects across more than 80 countries.
Shanghai Joozhou is an adsorbent and desiccant specialist. With over twenty years' experience, we are a global technology leader and key supplier in the sector.
Since its establishment, Shanghai Joozhou has firmly believed that solving fundamental technical challenges is key to driving industry progress. By deeply understanding customers' core needs across different scenarios, we have continuously pushed the performance boundaries of adsorption materials, starting from the central challenge of "moisture control." This has enabled us to gradually become the preferred partner for global clients in the adsorbent field.
Our comprehensive product portfolio includes:
We provide adsorption solutions for:
Our solutions deliver comprehensive support by:
In medical oxygen generation, our molecular sieves address the core challenges of nitrogen separation efficiency, moisture contamination, bed longevity, and regulatory compliance — providing complete adsorption solutions from material selection to system commissioning support.
Shanghai Joozhou is driven by one clear ambition: to become a global innovation leader in adsorption and new materials. We achieve this by:
We have established cooperative relationships with multiple Fortune 500 chemical companies and industry leaders. Our customers' trust drives us forward, and the consistent choice of leading enterprises in the industry validates the exceptional quality and reliability of our products and services.
From global PSA oxygen generator OEMs to hospital infrastructure developers and pharmaceutical manufacturers, Shanghai Joozhou's molecular sieve materials are the trusted choice wherever performance and reliability are non-negotiable.
"Shanghai Joozhou's adsorbents deliver stable performance, and their professional service team responds promptly. They have provided valuable technical solutions across multiple critical process areas and have become an indispensable part of our production chain."
For any inquiries regarding adsorption materials or technical questions, please feel free to contact us. Shanghai Joozhou looks forward to empowering your business with professional products and services.
Full-spectrum molecular sieve and adsorbent solutions for medical oxygen generation and beyond.
